Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Ferrando

Showing results (371-380 of 469) with videos related to

Pageof 47
Sort By:
Nature|January 18, 2018
Clonal evolution mechanisms in NT5C2 mutant-relapsed acute lymphoblastic leukaemiaGannie Tzoneva, Chelsea L Dieck, Koichi Oshima, et al.
The Journal of Surgical Research|July 30, 2025
Qualitative Analysis of Program Director Perspectives on Conscientious Objection Policies to Gender-Affirming CareRebecca Arteaga, Danielle J Eble, Alisha L Nguyen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 21, 2010
Absence of biallelic TCRgamma deletion predicts early treatment failure in pediatric T-cell acute lymphoblastic leukemiaAlejandro Gutierrez, Suzanne E Dahlberg, Donna S Neuberg, et al.
Nature Genetics|September 14, 2004
Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemiaC Graux, J Cools, C Melotte, et al.
Cell Reports|April 20, 2022
Oncogenic Vav1-Myo1f induces therapeutically targetable macrophage-rich tumor microenvironment in peripheral T cell lymphomaJose R Cortes, Ioan Filip, Robert Albero, et al.
Blood|June 5, 2009
WT1 mutations in T-ALLValeria Tosello, Marc R Mansour, Kelly Barnes, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 8, 2017
Activating mutations and translocations in the guanine exchange factor VAV1 in peripheral T-cell lymphomasFrancesco Abate, Ana C da Silva-Almeida, Sakellarios Zairis, et al.
Cancer Cell|December 3, 2013
Direct reversal of glucocorticoid resistance by AKT inhibition in acute lymphoblastic leukemiaErich Piovan, Jiyang Yu, Valeria Tosello, et al.
Blood Cancer Discovery|September 14, 2020
Combinatorial ETS1-dependent control of oncogenic NOTCH1 enhancers in T-cell leukemiaAnna C McCarter, Giusy Della Gatta, Ashley Melnick, et al.
Nature Medicine|December 4, 2019
A selective BCL-X<sub>L</sub> PROTAC degrader achieves safe and potent antitumor activitySajid Khan, Xuan Zhang, Dongwen Lv, et al.
Pageof 47

Showing results (371-380 of 469) with videos related to

Sort By:
Pageof 47
Nature|January 18, 2018
Clonal evolution mechanisms in NT5C2 mutant-relapsed acute lymphoblastic leukaemiaGannie Tzoneva, Chelsea L Dieck, Koichi Oshima, et al.
The Journal of Surgical Research|July 30, 2025
Qualitative Analysis of Program Director Perspectives on Conscientious Objection Policies to Gender-Affirming CareRebecca Arteaga, Danielle J Eble, Alisha L Nguyen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 21, 2010
Absence of biallelic TCRgamma deletion predicts early treatment failure in pediatric T-cell acute lymphoblastic leukemiaAlejandro Gutierrez, Suzanne E Dahlberg, Donna S Neuberg, et al.
Nature Genetics|September 14, 2004
Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemiaC Graux, J Cools, C Melotte, et al.
Cell Reports|April 20, 2022
Oncogenic Vav1-Myo1f induces therapeutically targetable macrophage-rich tumor microenvironment in peripheral T cell lymphomaJose R Cortes, Ioan Filip, Robert Albero, et al.
Blood|June 5, 2009
WT1 mutations in T-ALLValeria Tosello, Marc R Mansour, Kelly Barnes, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 8, 2017
Activating mutations and translocations in the guanine exchange factor VAV1 in peripheral T-cell lymphomasFrancesco Abate, Ana C da Silva-Almeida, Sakellarios Zairis, et al.
Cancer Cell|December 3, 2013
Direct reversal of glucocorticoid resistance by AKT inhibition in acute lymphoblastic leukemiaErich Piovan, Jiyang Yu, Valeria Tosello, et al.
Blood Cancer Discovery|September 14, 2020
Combinatorial ETS1-dependent control of oncogenic NOTCH1 enhancers in T-cell leukemiaAnna C McCarter, Giusy Della Gatta, Ashley Melnick, et al.
Nature Medicine|December 4, 2019
A selective BCL-X<sub>L</sub> PROTAC degrader achieves safe and potent antitumor activitySajid Khan, Xuan Zhang, Dongwen Lv, et al.
Pageof 47